BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18930984)

  • 41. Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
    Sahin E; Madendag Y; Sahin ME; Madendag IC; Acmaz G; Karakukcu C; Karaman H; Muderris II
    Cancer Control; 2018; 25(1):1073274818798598. PubMed ID: 30180755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study.
    Golubović M; Lopičić M; Terzić N; Đurović M; Mugoša B; Mijović G
    Vojnosanit Pregl; 2017 Jan; 74(1):24-30. PubMed ID: 29350503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
    Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
    Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions.
    Morrison C; Prokorym P; Piquero C; Wakely PE; Nuovo GJ
    Cancer; 2003 Apr; 99(2):75-82. PubMed ID: 12704686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
    Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
    Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Have we resolved how to triage equivocal cervical cytology?
    Solomon D; Schiffman M
    J Natl Cancer Inst; 2004 Feb; 96(4):250-1. PubMed ID: 14970266
    [No Abstract]   [Full Text] [Related]  

  • 47. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
    Arafa M; Boniver J; Delvenne P
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.
    Mo LZ; Monnier-Benoit S; Kantelip B; Petitjean A; Riethmuller D; Prétet JL; Mougin C
    J Clin Virol; 2008 Feb; 41(2):104-10. PubMed ID: 18036888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
    Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
    Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
    Lu W; Chen T; Yao Y; Chen P
    J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.
    Long W; Yang Z; Li X; Chen M; Liu J; Zhang Y; Sun X
    Virol J; 2018 May; 15(1):94. PubMed ID: 29801461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    Swan DC; Tucker RA; Tortolero-Luna G; Mitchell MF; Wideroff L; Unger ER; Nisenbaum RA; Reeves WC; Icenogle JP
    J Clin Microbiol; 1999 Apr; 37(4):1030-4. PubMed ID: 10074522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
    [No Abstract]   [Full Text] [Related]  

  • 58. The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis.
    Andersson S; Mints M; Sällström J; Wilander E
    Cancer Detect Prev; 2005; 29(1):37-41. PubMed ID: 15734215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
    Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.